共 18 条
[1]
Amino-Terminal Pro–B-Type Natriuretic Peptide Testing and Prognosis in Patients with Acute Dyspnea; Including Those with Acute Heart Failure.[J].Aaron L. Baggish;Roland R.J. van Kimmenade;James L. Januzzi.The American Journal of Cardiology.2008, 3
[2]
Outpatient Monitoring and Treatment of Chronic Heart Failure Guided by Amino-Terminal Pro–B-Type Natriuretic Peptide Measurement.[J].Richard W. Troughton;A. Mark Richards.The American Journal of Cardiology.2008, 3
[3]
Amino-Terminal Pro–B-Type Natriuretic Peptide Testing for Inpatient Monitoring and Treatment Guidance of Acute Destabilized Heart Failure.[J].Paulo Bettencourt;James L. Januzzi.The American Journal of Cardiology.2008, 3
[4]
Importance and Interpretation of Intermediate (Gray Zone) Amino-Terminal Pro–B-Type Natriuretic Peptide Concentrations.[J].Roland R.J. van Kimmenade;Yigal M. Pinto;James L. Januzzi.The American Journal of Cardiology.2008, 3
[5]
Amino-Terminal Pro–B-Type Natriuretic Peptide Testing to Assist the Diagnostic Evaluation of Heart Failure in Symptomatic Primary Care Patients.[J].Per Hildebrandt;Paul O. Collinson.The American Journal of Cardiology.2008, 3
[6]
The Differential Diagnosis of an Elevated Amino-Terminal Pro–B-Type Natriuretic Peptide Level.[J].Aaron L. Baggish;Roland R.J. van Kimmenade;James L. Januzzi.The American Journal of Cardiology.2008, 3
[7]
Biology of the Natriuretic Peptides.[J].Abelardo Martinez-Rumayor;A. Mark Richards;John C. Burnett;James L. Januzzi.The American Journal of Cardiology.2008, 3
[8]
Stability of B-type natriuretic peptide (BNP) in whole blood and plasma stored under different conditions when measured with the Biosite Triage or Beckman-Coulter Access systems.[J].Robert H. Christenson;Hassan M.E. Azzazy;Show Hong Duh.Clinica Chimica Acta.2007, 1

